Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic

Under the arrangement, prices for GLP-1 drugs—used both for diabetes and obesity—will be slashed for Medicare and Medicaid beneficiaries. The prices of Ozempic and Wegovy will fall from $1,000 and $1,
Medpage Today on MSN

Medicare to Cover Blockbuster Obesity Drugs

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with obesity, President Trump announced on Thursday.
Everyday Health on MSN

White House Slashes GLP-1 Costs, Permits Medicare Coverage for Obesity

A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist.
Becker's Hospital Review

Medicare to cover GLP-1s under Trump-negotiated pricing

Medicare cover GLP-1s under a Trump-negotiated pricing plan starting in 2026, lowering costs for key obesity and diabetes drugs.

Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access to them under two deals announced Thursday by the Trump administration.

Medicare to Cover GLP-1 Drugs for as Little as $50 a Month Under Trump Plan

Seniors could soon pay just $50 a month for Ozempic and other drugs used for weight loss under a new Trump plan to cut prescription costs.
InForum

Seniors must pick replacement for discontinued Medicare Advantage plans

Those covered by discontinued Medicare Advantage plans risk losing coverage if they do not pick a replacement plan during the annual enrollment period, which ends Dec. 7.

Do retirees really need supplemental coverage with Original Medicare?

Original Medicare provides valuable coverage, but it also comes with coverage gaps that can expose retirees to financial risk. A_Carina/ . For millions of retirees, tu
Feedback